Literature DB >> 35971028

Genetic diversity in Kashubs: the regional increase in the frequency of several disease-causing variants.

Maciej Jankowski1, Patrycja Daca-Roszak2, Cezary Obracht-Prondzyński3, Rafał Płoski4, Beata S Lipska-Ziętkiewicz5,6, Ewa Ziętkiewicz7.   

Abstract

Differential distribution of genetic variants' frequency among human populations is caused by the genetic drift in isolated populations, historical migrations, and demography. Some of these variants are identical by descent and represent founder mutations, which - if pathogenic in nature - lead to the increased frequency of otherwise rare diseases. The detection of the increased regional prevalence of pathogenic variants may shed light on the historical processes that affected studied populations and can help to develop effective screening and diagnostic strategies as a part of personalized medicine. Here, we discuss the specific genetic diversity in Kashubs, the minority group living in northern Poland, reflected in the biased distribution of some of the repetitively found disease-causing variants. These include the following: (1) c.662A > G (p.Asp221Gly) in LDLR, causing heterozygous familial hypercholesterolemia; (2) c.3700_3704del in BRCA1, associated with hereditary breast and ovarian cancer syndrome; (3) c.1528G > C (p.Glu510Gln) in HADHA, seen in long-chain 3-hydroxy acyl-CoA dehydrogenase (LCHAD) deficiency, and (4) c.1032delT in NPHS2, associated with steroid-resistant nephrotic syndrome.
© 2022. The Author(s).

Entities:  

Keywords:  Demography; Founder mutation; Kashubian; Polish population structure; Rare diseases

Year:  2022        PMID: 35971028     DOI: 10.1007/s13353-022-00713-z

Source DB:  PubMed          Journal:  J Appl Genet        ISSN: 1234-1983            Impact factor:   2.653


  63 in total

1.  Molecular characterization of Polish patients with familial hypercholesterolemia: novel and recurrent LDLR mutations.

Authors:  M Chmara; B Wasag; M Zuk; J Kubalska; A Wegrzyn; M Bednarska-Makaruk; E Pronicka; H Wehr; J C Defesche; A Rynkiewicz; J Limon
Journal:  J Appl Genet       Date:  2010       Impact factor: 3.240

2.  Clinical expression of familial hypercholesterolemia in clusters of mutations of the LDL receptor gene that cause a receptor-defective or receptor-negative phenotype.

Authors:  S Bertolini; A Cantafora; M Averna; C Cortese; C Motti; S Martini; G Pes; A Postiglione; C Stefanutti; I Blotta; L Pisciotta; M Rolleri; S Langheim; M Ghisellini; I Rabbone; S Calandra
Journal:  Arterioscler Thromb Vasc Biol       Date:  2000-09       Impact factor: 8.311

Review 3.  LDL-receptor mutations in Europe.

Authors:  George V Z Dedoussis; Hartmut Schmidt; Janine Genschel
Journal:  Hum Mutat       Date:  2004-12       Impact factor: 4.878

4.  High frequency of BRCA1/2 germline mutations in consecutive ovarian cancer patients in Poland.

Authors:  Izabela Brozek; Karolina Ochman; Jarosław Debniak; Lucyna Morzuch; Magdalena Ratajska; Magdalena Stepnowska; Maciej Stukan; Janusz Emerich; Janusz Limon
Journal:  Gynecol Oncol       Date:  2007-11-07       Impact factor: 5.482

Review 5.  Genetic causes of monogenic heterozygous familial hypercholesterolemia: a HuGE prevalence review.

Authors:  Melissa A Austin; Carolyn M Hutter; Ron L Zimmern; Steve E Humphries
Journal:  Am J Epidemiol       Date:  2004-09-01       Impact factor: 4.897

6.  NPHS2 (podicin) mutations in Turkish children with idiopathic nephrotic syndrome.

Authors:  Afig Berdeli; Sevgi Mir; Onder Yavascan; Erkin Serdaroglu; Mustafa Bak; Nejat Aksu; Ayse Oner; Ali Anarat; Osman Donmez; Nurhan Yildiz; Lale Sever; Yilmaz Tabel; Ruhan Dusunsel; Ferah Sonmez; Nilgun Cakar
Journal:  Pediatr Nephrol       Date:  2007-09-25       Impact factor: 3.714

7.  Clinical features and long-term outcome of nephrotic syndrome associated with heterozygous NPHS1 and NPHS2 mutations.

Authors:  Gianluca Caridi; Maddalena Gigante; Pietro Ravani; Antonella Trivelli; Giancarlo Barbano; Francesco Scolari; Monica Dagnino; Luisa Murer; Corrado Murtas; Alberto Edefonti; Landino Allegri; Alessandro Amore; Rosanna Coppo; Francesco Emma; Tommaso De Palo; Rosa Penza; Loreto Gesualdo; Gian Marco Ghiggeri
Journal:  Clin J Am Soc Nephrol       Date:  2009-04-30       Impact factor: 8.237

8.  Genetic diagnosis of steroid-resistant nephrotic syndrome in a longitudinal collection of Czech and Slovak patients: a high proportion of causative variants in NUP93.

Authors:  Martin Bezdíčka; Šárka Štolbová; Tomáš Seeman; Ondřej Cinek; Michal Malina; Naděžda Šimánková; Štěpánka Průhová; Jakub Zieg
Journal:  Pediatr Nephrol       Date:  2018-06-04       Impact factor: 3.714

9.  Limited significance of family history for presence of BRCA1 gene mutation in Polish breast and ovarian cancer cases.

Authors:  Izabela Brozek; Magdalena Ratajska; Magdalena Piatkowska; Anna Kluska; Aneta Balabas; Michalina Dabrowska; Dorota Nowakowska; Anna Niwinska; Jadwiga Rachtan; Jan Steffen; Janusz Limon
Journal:  Fam Cancer       Date:  2012-09       Impact factor: 2.375

10.  Prevalence of the most frequent BRCA1 mutations in Polish population.

Authors:  Izabela Brozek; Celina Cybulska; Magdalena Ratajska; Magdalena Piatkowska; Anna Kluska; Aneta Balabas; Michalina Dabrowska; Dorota Nowakowska; Anna Niwinska; Jolanta Pamula-Pilat; Karolina Tecza; Wioletta Pekala; Jolanta Rembowska; Karina Nowicka; Maria Mosor; Danuta Januszkiewicz-Lewandowska; Jadwiga Rachtan; Ewa Grzybowska; Jerzy Nowak; Jan Steffen; Janusz Limon
Journal:  J Appl Genet       Date:  2011-04-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.